The Research Subject Advocate (RSA) Office was created as part of the Clinical and Translational Research Science Award planning process to 1) ensure the safety and protection of human subjects, and 2) provide community education about processes in place to safeguard research subject safety within clinical and translational research trials and programs.
The UNMC Research Subject Advocate Office incorporates the Research Subject Advocacy Best Practices recommended by the Research Subject Advocacy Taskforce approved and endorsed by the CTSA Consortium Steering Committee in 2008.
The RSA is available to assist UNMC clinical and translational researchers in:
- developing protocols that minimize research subject risk and clearly communicate the risk-benefit ratio of study protocols
- reviews all research protocols submitted to the Center for Clinical and Translational Research requesting research support to identify any research subject safety concerns
- works closely with and extends the role of the IRB in assuring the safety of research subjects at UNMC through community outreach programs.
The RSA is also available to assist the community by:
- making presentations to community groups interested in learning more about or who have concerns about research and research subject safety, or to report any concerns about specific research projects